Natco Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE987B01026
  • NSEID: NATCOPHARM
  • BSEID: 524816
INR
1,171.90
-10 (-0.85%)
BSENSE

May 13

BSE+NSE Vol: 4.07 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 156274,
    "name": "Natco Pharma",
    "stock_name": "Natco Pharma",
    "full_name": "Natco Pharma Ltd.",
    "name_url": "stocks-analysis/natco-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,171.90",
    "chg": -10,
    "chgp": "-0.85%",
    "dir": -1,
    "prev_price": "1,181.90",
    "mcapval": "21,298.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524816,
    "symbol": "NATCOPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE987B01026",
    "curr_date": "May 13",
    "curr_time": "",
    "bse_nse_vol": "4.07 lacs",
    "exc_status": "Active",
    "traded_date": "May 13, 2026",
    "traded_date_str": "2026 05 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/natco-pharma-156274-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Natco Pharma Ltd. to 52-Week High of Rs 1226.1",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-hits-new-52-week-high-at-rs12261-3987046",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NatcoPharmaLtd_priceRelatedfactors_3987046.png",
        "date": "2026-05-12 09:40:07",
        "description": "With a 42.7% gain over the past year, Natco Pharma Ltd. has surged to a fresh 52-week high of Rs 1226.1 on 12 May 2026, defying the broader market’s downward trend. This milestone caps a sustained rally fuelled by a confluence of bullish technical indicators and robust price momentum."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Natco Pharma Ltd. to 52-Week High of Rs 1191.5",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-hits-new-52-week-high-at-rs11915-3981085",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NatcoPharmaLtd_priceRelatedfactors_3981085.png",
        "date": "2026-05-08 09:40:04",
        "description": "With a decisive surge to Rs 1191.5 on 8 May 2026, Natco Pharma Ltd. has reached a fresh 52-week high, extending its impressive rally that has delivered 47.35% returns over the past year. This milestone comes amid a backdrop of strong technical momentum, with the stock outperforming its sector and trading comfortably above all key moving averages."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Natco Pharma Ltd. to 52-Week High of Rs 1174.75",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-hits-new-52-week-high-at-rs117475-3979751",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NatcoPharmaLtd_priceRelatedfactors_3979751.png",
        "date": "2026-05-07 11:10:03",
        "description": "With a sustained five-day rally culminating in a fresh 52-week high of Rs 1174.75 on 7 May 2026, Natco Pharma Ltd. has demonstrated remarkable price momentum, outpacing its sector and the broader market over the past year."
      },
      {
        "title": "Natco Pharma Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-ltd-is-rated-hold-by-marketsmojo-3977686",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NatcoPharmaLtd_mojoScore_3977686.png",
        "date": "2026-05-06 10:10:03",
        "description": "Natco Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Natco Pharma Ltd. to 52-Week High of Rs 1149.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-hits-new-52-week-high-at-rs114915-3977291",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NatcoPharmaLtd_priceRelatedfactors_3977291.png",
        "date": "2026-05-06 09:41:16",
        "description": "With a steady climb over the past four sessions, Natco Pharma Ltd. has surged to a fresh 52-week high of Rs 1149.15 on 6 May 2026, marking a 36.11% gain over the last year and significantly outperforming the Sensex’s decline of 4.07% during the same period."
      },
      {
        "title": "Natco Pharma Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-ltd-is-rated-hold-by-marketsmojo-3962286",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NatcoPharmaLtd_mojoScore_3962286.png",
        "date": "2026-04-25 10:10:03",
        "description": "Natco Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance."
      },
      {
        "title": "Natco Pharma Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-ltd-is-rated-hold-by-marketsmojo-3945739",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NatcoPharmaLtd_mojoScore_3945739.png",
        "date": "2026-04-14 10:10:02",
        "description": "Natco Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 March 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 14 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and market performance."
      },
      {
        "title": "Natco Pharma Gains 7.33%: 5 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-gains-733-5-key-factors-driving-the-weeks-momentum-3943663",
        "imagepath": "",
        "date": "2026-04-12 16:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Technical momentum shifts signal bullish outlook</p>\n                    <p><strong>7 Apr:</strong> New 52-week high at Rs.1,075</p>\n                    <p><strong>8 Apr:</strong> Further 52-week high at Rs.1,113.8</p>\n                    <p><strong>9 Apr:</strong> New 52-week high at Rs.1,127.5 amid market weakness</p>\n                    <p><strong>10 Apr:</strong> Fresh 52-week high at Rs.1,134.9 closes the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.1,028.50</div>\n            ..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Natco Pharma Ltd. to 52-Week High of Rs 1134.9",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-hits-new-52-week-high-at-rs11349-3941201",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NatcoPharmaLtd_priceRelatedfactors_3941201.png",
        "date": "2026-04-10 09:40:05",
        "description": "With a sustained seven-day rally culminating in a fresh 52-week high of Rs 1134.9 on 10 Apr 2026, Natco Pharma Ltd. has demonstrated remarkable price momentum, outpacing its sector and the broader market over the past year."
      }
    ],
    "total": 5641,
    "sid": "156274",
    "stock_news_url": "https://www.marketsmojo.com/news/natco-pharma-156274"
  },
  "announcements": [
    {
      "details": "Natco Pharma Limited has informed the Exchange regarding Investor Presentation Q2 FY 2019-2020",
      "source": "NSE",
      "caption": "Natco Pharma Limited - Investor Presentation",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Natco Pharma Limited has informed the Exchange regarding a press release dated November 14, 2019, titled \"Commercial Manufacturing Operations begin in NATCO s Visakhapatnam Formulation Facility \".",
      "source": "NSE",
      "caption": "Natco Pharma Limited - Press Release",
      "datetime": "15-Nov-2019"
    },
    {
      "details": "Natco Pharma Limited has informed the Exchange regarding a press release dated November 12, 2019, titled \"NATCO records INR 518.9 Crore consolidated revenue and INR 117.7 Crore of profit, after tax, for the Second Quarter, FY2019-20\".",
      "source": "NSE",
      "caption": "Natco Pharma Limited - Press Release",
      "datetime": "13-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has declared <strong>75%</strong> dividend, ex-date: 18 Feb 26",
          "dt": "2026-02-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has announced <strong>2:10</strong> stock split, ex-date: 26 Nov 15",
          "dt": "2015-11-26",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Natco Pharma Limited - Investor Presentation

18-Nov-2019 | Source : NSE

Natco Pharma Limited has informed the Exchange regarding Investor Presentation Q2 FY 2019-2020

Natco Pharma Limited - Press Release

15-Nov-2019 | Source : NSE

Natco Pharma Limited has informed the Exchange regarding a press release dated November 14, 2019, titled "Commercial Manufacturing Operations begin in NATCO s Visakhapatnam Formulation Facility ".

Natco Pharma Limited - Press Release

13-Nov-2019 | Source : NSE

Natco Pharma Limited has informed the Exchange regarding a press release dated November 12, 2019, titled "NATCO records INR 518.9 Crore consolidated revenue and INR 117.7 Crore of profit, after tax, for the Second Quarter, FY2019-20".

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Natco Pharma Ltd. has declared 75% dividend, ex-date: 18 Feb 26

stock-summary
SPLITS

Natco Pharma Ltd. has announced 2:10 stock split, ex-date: 26 Nov 15

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available